临床肝胆病杂志2025，Vol.41Issue(6)：1001-1007,7.DOI:10.12449/JCH250601
中西医结合在慢加急性肝衰竭全病程管理中的特色和优势
Characteristics and advantages of integrated traditional Chinese and Western medicine therapy in whole-course management of acute-on-chronic liver failure
摘要
Abstract
Acute-on-chronic liver failure(ACLF)is a complex clinical syndrome characterized by acute deterioration of liver function caused by different factors on the basis of chronic liver disease,accompanied by liver failure and/or extrahepatic organ failure,and it often has a high short-term mortality rate.With the increasing evidence of evidence-based medicine,multiple guidelines and consensus statements have been released,such as Guidelines for clinical diagnosis and treatment of acute-on-chronic liver failure in traditional Chinese medicine,Expert consensus on the diagnosis and treatment of acute-on-chronic liver failure with integrated traditional Chinese and Western medicine,and Guidelines for the integrated traditional Chinese and Western medicine diagnosis and treatment of acute-on-chronic liver failure,and integrated traditional Chinese and Western medicine therapies for ACLF have been constantly standardized and perfected.This article explores the characteristics and advantages of integrated traditional Chinese and Western medicine therapy in the whole-course management of ACLF from the aspects of early warning and prevention,treatment in the acute stage,management of complications,and rehabilitation care,in order to enhance the understanding of traditional Chinese and Western medicine treatment strategies among clinicians.关键词
慢加急性肝功能衰竭/中西医结合疗法/多学科诊疗Key words
Acute-On-Chronic Liver Failure/Integrated Chinese Traditional and Western Medicine Therapy/Multi-Disciplinary Team引用本文复制引用
高方媛,冯颖,王宪波..中西医结合在慢加急性肝衰竭全病程管理中的特色和优势[J].临床肝胆病杂志,2025,41(6):1001-1007,7.基金项目
国家自然科学基金(82474419,82474426) （82474419,82474426）
北京市卫生健康委员会-研究型病房卓越临床研究计划(BRWEP2024W102170107) （BRWEP2024W102170107）
北京市医院管理中心创新梦工场经费资助(202335) National Natural Science Foundation of China(82474419,82474426) （202335）
Beijing Municipal Health Commission-Excellent Clinical Research Program for Research Wards(BRWEP2024W102170107) （BRWEP2024W102170107）
Beijing Hospitals Authority Innovation Studio of Young Staff Funding Support(202335) （202335）
